Search Results - "Hiemenz, John W."

Hematopoietic Stem Cell Transplantation: An Overview of Infection Risks and Epidemiology by Wingard, John R., MD, Hsu, Jack, MD, Hiemenz, John W., MD

“…Hematopoietic stem cell transplantation (HSCT) is a treatment for multiple medical conditions that result in bone marrow failure and as an antineoplastic…”
Get full text

Micafungin versus Fluconazole for Prophylaxis against Invasive Fungal Infections during Neutropenia in Patients Undergoing Hematopoietic Stem Cell Transplantation by van Burik, Jo-Anne H., Ratanatharathorn, Voravit, Stepan, Daniel E., Miller, Carole B., Lipton, Jeffrey H., Vesole, David H., Bunin, Nancy, Wall, Donna A., Hiemenz, John W., Satoi, Yoichi, Lee, Jeanette M., Walsh, Thomas J.

“…We hypothesized that chemoprophylaxis with the echinocandin micafungin would be an effective agent for antifungal prophylaxis during neutropenia in patients…”
Get full text

Management of Infections Complicating Allogeneic Hematopoietic Stem Cell Transplantation by Hiemenz, John W

“…The use of allogeneic hematopoietic stem cell transplantation for the treatment of hematologic malignancies, as well as some benign hematologic disorders, has…”
Get full text

Pattern of brexucabtagene autoleucel-related neurotoxicity on magnetic resonance imaging of the brain in a patient with relapsed/refractory B-cell acute lymphoblastic leukemia and prior leptomeningeal disease by Dean, Erin A., Peters, Keith R., Adams, Carolyn B., Hiemenz, John W.

“…Immune effector cell-associated neurotoxicity syndrome (ICANS) secondary to chimeric antigen receptor T-cell therapy is common in adult patients with…”
Get full text

Hematopoietic Stem Cell Transplantation: An Overview of Infection Risks and Epidemiology by Wingard, John R., MD, Hsu, Jack, MD, Hiemenz, John W., MD

“…Hematopoietic stem cell transplantation (HSCT) is a treatment for multiple medical conditions that result in bone marrow failure and as an antineoplastic…”
Get full text

Melflufen and Dexamethasone in Heavily Pretreated Relapsed and Refractory Multiple Myeloma by Richardson, Paul G, Oriol, Albert, Larocca, Alessandra, Bladé, Joan, Cavo, Michele, Rodriguez-Otero, Paula, Leleu, Xavier, Nadeem, Omar, Hiemenz, John W, Hassoun, Hani, Touzeau, Cyrille, Alegre, Adrián, Paner, Agne, Maisel, Christopher, Mazumder, Amitabha, Raptis, Anastasios, Moreb, Jan S, Anderson, Kenneth C, Laubach, Jacob P, Thuresson, Sara, Thuresson, Marcus, Byrne, Catriona, Harmenberg, Johan, Bakker, Nicolaas A, Mateos, María-Victoria

“…Melphalan flufenamide (melflufen) is a first-in-class peptide-drug conjugate that targets aminopeptidases and rapidly and selectively releases alkylating…”
Get full text

How I manage pulmonary nodular lesions and nodular infiltrates in patients with hematologic malignancies or undergoing hematopoietic cell transplantation by Wingard, John R., Hiemenz, John W., Jantz, Michael A.

“…Pulmonary nodules and nodular infiltrates occur frequently during treatment of hematologic malignancies and after hematopoietic cell transplantation. In…”
Get full text

Transthyretin Cardiac Amyloidosis Disguised as Light Chain Amyloidosis or Multiple Myeloma? by Stein, Andrew P, Matthia, Eldon L, Petty, Stephen A, Stewart, Brian, Vilaro, Juan R, Al-Ani, Mohammad A Z, Ahmed, Mustafa M, Aranda, Jr, Juan M, Hiemenz, John W, Parker, Alex M

“…We describe 2 challenging cases of cardiac transthyretin amyloidosis initially treated as cardiac amyloidosis light chain in the setting of active myeloma…”
Get full text

Impact of the CYP2C19 genotype on voriconazole exposure in adults with invasive fungal infections by Hamadeh, Issam S, Klinker, Kenneth P, Borgert, Samuel J, Richards, Ashley I, Li, Wenhui, Mangal, Naveen, Hiemenz, John W, Schmidt, Stephan, Langaee, Taimour Y, Peloquin, Charles A, Johnson, Julie A, Cavallari, Larisa H

“…OBJECTIVESVoriconazole, a first-line agent for the treatment of invasive fungal infections (IFIs), is metabolized by CYP2C19. A significant proportion of…”
Get full text

Central nervous system manifestations as initial presentation of plasma cell disorders: Differential management of 3 cases based on disease extent by McGrath, Kyle, Fenton, Graeme A., Seifert, Robert P., Peters, Keith R., Hiemenz, John W., Dean, Erin A.

“…Central nervous system (CNS) manifestations of plasma cell neoplasms are exceedingly uncommon. CNS multiple myeloma (MM) carries a dismal prognosis, and…”
Get full text

Need for Alternative Trial Designs and Evaluation Strategies for Therapeutic Studies of Invasive Mycoses by Rex, John H., Walsh, Thomas J., Nettleman, Mary, Anaissie, Elias J., Bennett, John E., Bow, Eric J., Carillo-Munoz, A. J., Chavanet, Pascal, Cloud, Gretchen A., Denning, David W., de Pauw, Ben E., Edwards, John E., Hiemenz, John W., Kauffman, Carol A., Lopez-Berestein, Gabriel, Martino, Pietro, Sobel, Jack D., Stevens, David A., Sylvester, Richard, Tollemar, Jan, Viscoli, Claudio, Viviani, Maria A., Wu, Teresa

“…Studies of invasive fungal infections have been and remain difficult to implement. Randomized clinical trials of fungal infections are especially slow and…”
Get full text

A New Model to Predict Remission Status in AML Patients Based on Day 14 Bone Marrow Biopsy by Norkin, Maxim, Chang, Myron, An, Qi, Leather, Helen, Katragadda, Lakshmikanth, Li, Ying, Moreb, Jan S, May, W. Stratford, Brown, Randy A, Hsu, Jack W, Hiemenz, John W, Wingard, John R, Cogle, Christopher R

“…Highlights • A new model for interpreting Day 14 bone marrow biopsy results in patients AML was developed. • This model incorporates both clinical had…”
Get full text

Amphotericin B Lipid Complex for Invasive Fungal Infections: Analysis of Safety and Efficacy in 556 Cases by Walsh, Thomas J., Hiemenz, John W., Seibel, Nita L., Perfect, John R., Horwith, Gary, Lee, Lily, Silber, Jeffrey L., DiNubile, Mark J., Reboli, Annette, Bow, Eric, Lister, John, Anaissie, Elias J.

“…The safety and antifungal efficacy of amphotericin B lipid complex (ABLC) were evaluated in 556 cases of invasive fungal infection treated through an…”
Get full text

Survivor and Caregiver Expectations and Preferences Regarding Lung Cancer Treatment by Wieland, Jana, Hoppe, Bradford S, Rausch-Osian, Sarah M, King, Jennifer C, Sierra, Alexandra, Hiemenz, John W, Bradley, Julie, Pham, Dat C, Jones, Lisa M, Yeung, Anamaria R, Hopper, Keri, Mendenhall, Nancy P, Hitchcock, Kathryn E

“…Treatment success in lung cancer is no longer restricted to objective measures of disease-specific outcomes and overall survival alone but now incorporates…”
Get full text

Lipid Formulations of Amphotericin B: Recent Progress and Future Directions by Hiemenz, John W., Walsh, Thomas J.

“…Three lipid formulations of amphotericin B are now either marketed for clinical use or undergoing further study before they can be approved in various…”
Get full text

A genomics-informed computational biology platform prospectively predicts treatment responses in AML and MDS patients by Drusbosky, Leylah M., Singh, Neeraj Kumar, Hawkins, Kimberly E., Salan, Cesia, Turcotte, Madeleine, Wise, Elizabeth A., Meacham, Amy, Vijay, Vindhya, Anderson, Glenda G., Kim, Charlie C., Radhakrishnan, Saumya, Ullal, Yashaswini, Talawdekar, Anay, Sikora, Huzaifa, Nair, Prashant, Khanna-Gupta, Arati, Abbasi, Taher, Vali, Shireen, Guha, Subharup, Farhadfar, Nosha, Murthy, Hemant S., Horn, Biljana N., Leather, Helen L., Castillo, Paul, Tucker, Caitlin, Cline, Christina, Pettiford, Leslie, Lamba, Jatinder K., Moreb, Jan S., Brown, Randy A., Norkin, Maxim, Hiemenz, John W., Hsu, Jack W., Slayton, William B., Wingard, John R., Cogle, Christopher R.

“…Patients with myelodysplastic syndromes (MDS) or acute myeloid leukemia (AML) are generally older and have more comorbidities. Therefore, identifying…”
Get full text

Amphotericin B Deoxycholate Administered by Continuous Infusion: Does the Dosage Make a Difference? by Hiemenz, John W.

Get full text

Dietary Intake and Diet Quality of Hematopoietic Stem Cell Transplantation Survivors by Farhadfar, Nosha, Kelly, Debra L., Mead, Lacey, Nair, Shalini, Colee, James, Irizarry Gatell, Vivian, Murthy, Hemant S., Brown, Randy A., Hiemenz, John W., Hsu, Jack W., May, William S., Wingard, John R., Dahl, Wendy J.

“…•Long-term survivors of hematopoietic stem cell transplantation (HCT) reported less than optimal adherence to the 2015-2020 Dietary Guidelines for Americans…”
Get full text

Amphotericin B Colloidal Dispersion vs. Amphotericin B as Therapy for Invasive Aspergillosis by Mary H. White, Elias J. Anaissie, Shimon Kusne, John R. Wingard, John W. Hiemenz, Cantor, Alan, Marc Gurwith, Charles Du Mond, Richard D. Mamelok, Raleigh A. Bowden

“…To assess the efficacy and safety of amphotericin B colloidal dispersion (ABCD), 82 patients with proven or probable aspergillosis who were treated in clinical…”
Get full text

Nocardiosis After Bone Marrow Transplantation: A Retrospective Study by van Burik, Jo-Anne, Hackman, Robert C., Nadeem, Sahba Q., Hiemenz, John W., White, Mary H., Flowers, Mary E. D., Bowden, Raleigh A.

“…To evaluate the spectrum of nocardiosis after marrow transplantation, we reviewed the medical records of 27 patients with nocardiosis who were treated at three…”
Get full text